Cytomegalovirus infection after liver transplantation: Current concepts and challenges

doi:10.3748/wjg.14.4849

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2646)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

309

HTML

1918

Figures (1-2)

204

Tables (1-3)

215

Sum=2646

Aug 21, 2008 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (161)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Aug 21, 2008; 14(31): 4849-4860
Published online Aug 21, 2008. doi: 10.3748/wjg.14.4849

Full Size Figure Download Figure

Figure 2 The proportion of solid organ transplant patients with resolution of clinical symptoms (A) and viremia eradication (B) at day 21 and 49 following the start of valganciclovir or IV ganciclovir treatment of CMV disease. Data obtained from the study by Asberg et al[81].

Citation: Razonable RR. Cytomegalovirus infection after liver transplantation: Current concepts and challenges. World J Gastroenterol 2008; 14(31): 4849-4860
URL: https://www.wjgnet.com/1007-9327/full/v14/i31/4849.htm
DOI: https://dx.doi.org/10.3748/wjg.14.4849